AustralianSuper’s AbbVie ABBV Stock Holding History

AustralianSuper’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107M	Buy	426,658 +222,509	+109%	+$47.9M	0.46%	60
2026 Q1	$44.4M	Sell	204,149 -14,544	-7%	-$3.23M	0.23%	93
2025 Q4	$50M	Buy	218,693 +3,070	+1%	+$699K	0.23%	85
2025 Q3	$49.9M	Buy	215,623 +207,971	+2,718%	+$42.4M	0.24%	84
2025 Q2	$1.42M	Buy	7,652 +18	+0.2%	+$3.35K	0.01%	232
2025 Q1	$1.6M	Buy	+7,634	New	+$1.48M	0.01%	190
2024 Q3	–	Sell	-9,078	Closed	-$1.56M	–	239
2024 Q2	$1.56M	Buy	9,078 +707	+8%	+$117K	0.01%	185
2024 Q1	$1.51M	Sell	8,371 -820,290	-99%	-$141M	0.01%	189
2023 Q4	$128M	Buy	828,661 +819,251	+8,706%	+$119M	0.77%	37
2023 Q3	$1.4M	Buy	+9,410	New	+$1.38M	0.01%	209

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AustralianSuper's ABBV Position: Q2 2026 in Review

AustralianSuper increased its AbbVie (ABBV) stake by 109% in Q2 2026, buying an estimated $47.9M and bringing the position to 426,658 shares worth $107M. The position accounts for 0.46% of the portfolio, ranked #60.

AustralianSuper first reported a position in ABBV in Q3 2023 and has held it in 10 quarters since. The position peaked at $128M in Q4 2023. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

AustralianSuper held 426,658 shares of AbbVie worth $107M as of Q2 2026.
AustralianSuper bought 222,509 AbbVie shares in Q2 2026, an estimated $47.9M.
AbbVie made up 0.46% of AustralianSuper's portfolio in Q2 2026, its #60 holding.
AustralianSuper first reported a position in AbbVie in Q3 2023 and has held it in 10 quarters since.
AustralianSuper's AbbVie position peaked at $128M in Q4 2023.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.